Abstract
The world must act fast to contain wider international spread of the epidemic of COVID-19 now. The unprecedented public health efforts in China have contained the spread of this new virus. Measures taken in China are currently proven to reduce human-to-human transmission successfully. We summarized the effective intervention and prevention measures in the fields of public health response, clinical management, and research development in China, which may provide vital lessons for the global response. It is really important to take collaborative actions now to save more lives from the pandemic of COVID-19.
Keywords: coronavirus disease 2019 (COVID-19), control measure, public health response
Acknowledgements
This work is funded by Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University (No. YG2020YQ06), the National Key Research and Development Project (Nos. 2018YFC1705100 and 2018YFC1705103) and the National Natural Science Foundation of China (No. 71673187). We acknowledge all healthcare workers involved in the diagnosis and treatment of patients all around China. We thank National Health Commission of the People’s Republic of China for coordinating data collection for patients with COVID-19.
Compliance with ethics guidelines
Shuxian Zhang, Zezhou Wang, Ruijie Chang, Huwen Wang, Chen Xu, Xiaoyue Yu, Lhakpa Tsamlag, Yinqiao Dong, Hui Wang, and Yong Cai declare no conflicts of interest. This manuscript is a commentary and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
Footnotes
Shuxian Zhang and Zezhou Wang contributed equally to this manuscript.
Contributor Information
Hui Wang, Email: huiwang@shsmu.edu.cn.
Yong Cai, Email: caiyong202028@hotmail.com.
References
- 1.WHO. Coronavirus disease 2019 (covid-19) situation. report-47. 2020. [Google Scholar]
- 2.The National Health Commission of the People’s Republic of China. Report on 2019-nCoV. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 2020. [Google Scholar]
- 4.The Health Commission of Wuhan. 41 COVID-19 patients were confirmed in Wuhan. 2020. [Google Scholar]
- 5.Hubei Provincial Government. Notice on Wuhan novel coronavirus infection of pneumonia epidemic prevention and control. 2020. [Google Scholar]
- 6.The Ministry of Financethe National Health Commission of the People’s Republic of China. China issues 9.95b yuan additional funds for public health, epidemic control. 2020. [Google Scholar]
- 7.The State Council of the People’s Republic of China. The notice on orderly resuming production and resuming production in enterprises. 2020. [Google Scholar]
- 8.The National DevelopmentReform Commission of the People’s Republic of China. China’s daily mask output exceeds 110 million units. 2020. [Google Scholar]
- 9.Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, Zhang S, Tsamlag L, Shang M, Huang J, Wang Y, Xu G, Shen T, Zhang X, Cai Y. Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discov. 2020;6(1):10. doi: 10.1038/s41421-020-0148-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wuhan Municipal Government. Wuhan Huoshenshan Hospital was completed today. 2020. [Google Scholar]
- 11.Hubei Provincial Government. Wuhan Leishenshan Hospital welcomed its first confirmed 2019-nCoV patients. 2020. [Google Scholar]
- 12.The State Council. Press Conference of the joint Prevention and Control Mechanism of the State Council. 2020. [Google Scholar]
- 13.General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine. Diagnostic and treatment protocol for novel coronavirus pneumonia (Trial version 7) 2020. [Google Scholar]
- 14.Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. Nature. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus inWuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JTK, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. N Engl J Med. 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wu Z, McGoogan JM. JAMA. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for 4 COVID-19 containment: China provides important lessons for global response Disease Control and Prevention. [DOI] [PubMed] [Google Scholar]
- 20.Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discov. 2020;19(3):149–150. doi: 10.1038/d41573-020-00016-0. [DOI] [PubMed] [Google Scholar]
- 21.Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689–697. doi: 10.1016/S0140-6736(20)30260-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Li J, Wang Y, Gilmour S, et al. medRxiv. 2020. Estimation of the epidemic properties of the 2019 novel coronavirus: a mathematical modeling study. [Google Scholar]
- 23.The Chinese Center for Disease ControlPrevention. China CDC publishes multilingual epidemic control manuals for COVID-19. 2020. [Google Scholar]